Can stem cells restore dopamine production in Parkinson's patients?

The answer

In 2025-2026, a groundbreaking clinical trial began testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson's disease. Parkinson's is caused by the death of dopamine-producing neurons in the substantia nigra region of the brain, leading to tremors, rigidity, and movement difficulties. The trial uses lab-grown dopaminergic neurons derived from induced pluripotent stem cells (iPSCs) - adult cells reprogrammed back into a stem cell state and then guided to become dopamine neurons. These engineered neurons are surgically implanted into the brain, where they integrate with existing neural circuits and begin producing dopamine. Early results have shown measurable improvements in motor function.